The concept of innovative drugs shows active performance, and AstraZeneca hit the daily limit.

The concept of innovative drugs is active, AstraZeneca hits the limit up, Jin Medicine, Frontier Biotech, Zetin Pharmaceuticals, and Weikang Medicine followed the rise.